Bundesliga CEO Sends Clear Message To Chelsea Over Deal for Brilliant Midfielder

Bayer Leverkusen CEO Carro has sent a clear message to the likes of Chelsea and Liverpool. It is no secret that CHELSEA, have been one of the biggest spenders in the transfer windows over the last few seasons, and it is also no secret that Mauricio Pochettino wants to add a bit more quality to the side....CONTINUE READING

And that has led to reports that Chelsea will once again delve into that transfer kitty in the summer window and try to add a few new players, with Wirtz a man that the club now want,

PAY ATTENTION:   AFCON: Drama in Nigeria’s Camp As Senior Player Blames Super Eagles’ Loss on Peseiro’s Tactics

The 20-year-old forward is one of the rising stars of European football and reports that the Blues hold a ‘strong interest’ in the Germany international. It is said that Wirtz is on the club’s ‘radar’ as a possible replacement for Raheem Sterling, who has been tipped to leave the club in the summer.

However – any hope of getting the player has been played down by Carro::“Florian Wirtz will stay with us next season. The plan is clear, together with his father”. “There’s interest from many clubs, we can’t plan too long in football… but he’s staying”. “He could win the Ballon d’Or one day”,told AS
IcFootballnews View…

PAY ATTENTION:   Texas Weather Attacks ‘Skinny’ Victor Wembanyama as Spurs Star Reveals Challenging “Immune System”

Look, Wirtz is a very exciting talent that has had a brilliant start to the new season, but he is not a man that will come in and make much of an impact for Pochettino, he needs to add some experience.

There are better players out there that CHELSEA

should sign, there are players on the market that have done alot more in the game and there are players out there that could make an impact now.

PAY ATTENTION:   Sterling starts, Mudryk benched, Palmer switch – Chelsea lineups for Man City FA Cup clash

So even though he has had a brilliant season – it is probably the best thing that he stays put at Bayer.